Effect of cimetidine, bicarbonate and glucose on the bioavailability of different formulations of praziquantel.
The effects of cimetidine, bicarbonate and glucose on the bioavailability of the two brands of praziquantel (CAS 55268-74-1) available in Egypt were studied in normal healthy volunteers. Brand 1 when coadministered with cimetidine showed elevated concentration of the drug at all time intervals. The difference was statistically significant at 3, 4, 6 and 8 h following treatment. On the other hand coadministration of cimetidine with brand 2 (Distocide) showed elevated concentration of the drug 1 h post treatment. Analysis of the pharmacokinetic parameters revealed insignificant difference comparing brand 1 versus brand 1 plus cimetidine. Significant differences were observed between the elimination rate constant Ke (h-1) for brand 2 (0.017 +/- 0.004) alone versus brand 2 plus cimetidine (0.006 +/- 0.001). Coadministration of bicarbonate or glucose with either brand 2 or brand 1 tended to depress the serum concentration of praziquantel. Possible explanations of these findings are discussed.
Metwally
A
A
Department of Pharmacology, Theodor Bilharz Research Institute, Giza, Egypt.
Bennett
J L
JL
Botros
S
S
Ebeid
F
F
D000293:Adolescent; D000328:Adult; D001639:Bicarbonates / Q000494:pharmacology*; D001682:Biological Availability; D002927:Cimetidine / Q000494:pharmacology*; D005947:Glucose / Q000494:pharmacology*; D006801:Humans; D008297:Male; D011223:Praziquantel / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*
D001639:Bicarbonates; D011223:Praziquantel; D002927:Cimetidine; D005947:Glucose